Amorphous, Eosinophilic, and Acellular Deposit
1 clinical trials · Condition
◉ Watch Amorphous, Eosinophilic, and Acellular Deposit
| Record | Firm | Date |
|---|---|---|
| S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis (NCT03499808) | SWOG Cancer Research Network | 2018-06-06 |
Track Amorphous, Eosinophilic, and Acellular Deposit automatically
Every clearance here is in the API, with alerts when new ones post.